Position in RLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$620,522
+$464,326 QoQ
Shares Held
89,671
+299.6% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 126 holders
Holding Since
Mar 2020
9 quarters on record
Voting authority
Sole 0%
Shared 97%
None 3%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. RLMD ranks #176 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in RLMD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $620,522 | 89,671 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $156,196 | 22,442 | Shares | Defined | 2026-05-12 | |
| 2022-09-30 | $4,229,349 | 114,245 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $202,564 | 10,667 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $246,202 | 9,122 | Shares | Defined | 2022-05-16 | |
| 2020-12-31 | $8,567,660 | 267,155 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,967,982 | 264,965 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $14,442,659 | 322,741 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,077,284 | 266,118 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||